AVTX Operating Income - Avalo Therapeutics, Inc.

Complete source-backed operating income history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Operating Income

Date	Operating Income
2026-06-30	-$31.52M
2026-03-31	-$20.9M
2025-12-31	-$19.74M
2025-09-30	-$19.2M
2025-06-30	-$19.32M
2025-03-31	-$14.67M
2024-12-31	-$13.31M
2024-09-30	-$12.86M
2024-06-30	-$9.58M
2024-03-31	-$32.77M
2023-12-31	-$7.66M
2023-09-30	-$3.75M
2023-06-30	-$7.15M
2023-03-31	-$8.79M
2022-12-31	-$8.86M
2022-09-30	$4.1M
2022-06-30	-$11.83M
2022-03-31	-$20.85M
2021-12-31	-$17.96M
2021-09-30	-$16.46M
2021-06-30	-$17.13M
2021-03-31	-$30.58M
2020-12-31	-$16.34M
2020-09-30	-$13.28M
2020-06-30	-$11.82M
2020-03-31	-$31.41M
2019-12-31	-$5.72M
2019-09-30	-$2.86M
2019-06-30	-$2.55M
2019-03-31	-$5M
2018-12-31	-$1.56M
2018-09-30	-$24.31M
2018-06-30	-$5.75M
2018-03-31	-$3.75M
2017-12-31	-$4.36M
2017-09-30	$21.92M
2017-06-30	-$1.77M
2017-03-31	-$1.9M
2016-12-31	-$1.69M
2016-09-30	-$5.96M
2016-06-30	-$3.49M
2016-03-31	-$4.94M
2015-12-31	-$3.68M
2015-09-30	-$1.96M
2015-06-30	-$2.89M
2015-03-31	-$2.48M
2014-12-31	-$3.83M
2014-09-30	-$6M

Annual Operating Income

Date	Operating Income
2025-12-31	-$72.93M
2024-12-31	-$68.51M
2023-12-31	-$27.35M
2022-12-31	-$37.44M
2021-12-31	-$82.13M
2020-12-31	-$72.84M
2019-12-31	-$16.14M
2018-12-31	-$35.38M
2017-12-31	$13.89M
2016-12-31	-$16.08M
2015-12-31	-$11.01M
2014-12-31	-$17.12M
2013-12-31	-$12.93M